Deborah Cosentini

1.1k total citations
59 papers, 539 citations indexed

About

Deborah Cosentini is a scholar working on Surgery, Cancer Research and Genetics. According to data from OpenAlex, Deborah Cosentini has authored 59 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 28 papers in Cancer Research and 15 papers in Genetics. Recurrent topics in Deborah Cosentini's work include Adrenal and Paraganglionic Tumors (27 papers), Cancer, Hypoxia, and Metabolism (26 papers) and Glioma Diagnosis and Treatment (15 papers). Deborah Cosentini is often cited by papers focused on Adrenal and Paraganglionic Tumors (27 papers), Cancer, Hypoxia, and Metabolism (26 papers) and Glioma Diagnosis and Treatment (15 papers). Deborah Cosentini collaborates with scholars based in Italy, Germany and Canada. Deborah Cosentini's co-authors include Salvatore Grisanti, Alfredo Berruti, Sandra Sigala, Marta Laganà, Alfredo Berruti, Andrea Abate, Massimo Terzolo, Elisa Rossini, Guido Alberto Massimo Tiberio and Rebecca Pedersini and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Deborah Cosentini

51 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah Cosentini Italy	14	313	268	164	145	127	59	539
Yuchun Zhu China	14	215 0.7×	122 0.5×	39 0.2×	161 1.1×	48 0.4×	47	484
Luigi Marzano Italy	16	513 1.6×	135 0.5×	51 0.3×	509 3.5×	32 0.3×	36	857
Alex E. Henney United Kingdom	6	76 0.2×	225 0.8×	25 0.2×	46 0.3×	39 0.3×	10	473
Maurizio Poggi Italy	14	238 0.8×	41 0.2×	160 1.0×	285 2.0×	24 0.2×	37	675
Cristina Falcó Spain	16	84 0.3×	78 0.3×	60 0.4×	98 0.7×	16 0.1×	19	567
Niels Borgstein United States	12	54 0.2×	48 0.2×	58 0.4×	54 0.4×	75 0.6×	21	594
Gitanjali Paul United States	8	158 0.5×	20 0.1×	65 0.4×	294 2.0×	111 0.9×	11	634
Krystyna Wyka Poland	14	195 0.6×	26 0.1×	20 0.1×	123 0.8×	52 0.4×	53	525
Anli Tong China	17	357 1.1×	111 0.4×	27 0.2×	423 2.9×	49 0.4×	65	645

Countries citing papers authored by Deborah Cosentini

Since Specialization

Citations

This map shows the geographic impact of Deborah Cosentini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Cosentini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Cosentini more than expected).

Fields of papers citing papers by Deborah Cosentini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Cosentini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Cosentini. The network helps show where Deborah Cosentini may publish in the future.

Co-authorship network of co-authors of Deborah Cosentini

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Cosentini. A scholar is included among the top collaborators of Deborah Cosentini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Cosentini. Deborah Cosentini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moretti, Laura, Marta Laganà, Marco Ravanelli, et al.. (2026). Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy. Breast Cancer Research and Treatment. 215(2). 58–58.

Gallo, Fabio, Massimo Salvetti, Giulia Carola, et al.. (2025). Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study. Endocrine Related Cancer. 32(12).

Altieri, Barbara, Marta Laganà, Thomas J. Vogl, et al.. (2024). The Value of Local Therapies in Advanced Adrenocortical Carcinoma. Cancers. 16(4). 706–706. 4 indexed citations

Laganà, Marta, Manuel Zamparini, Vito Amoroso, et al.. (2024). Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?. The Breast. 78. 103794–103794.

Abate, Andrea, Elisa Rossini, Ram Manohar Basnet, et al.. (2023). Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines. International Journal of Molecular Sciences. 24(7). 6829–6829. 6 indexed citations

Pedersini, Rebecca, Deborah Cosentini, Rosalba Torrisi, et al.. (2023). Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors. Journal of Endocrinological Investigation. 47(2). 433–442. 6 indexed citations

Laganà, Marta, Andrea Abate, Manuel Zamparini, et al.. (2023). Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status. Cancers. 15(18). 4491–4491.

Laganà, Marta, et al.. (2023). The Evolving Treatment Landscape of Medullary Thyroid Cancer. Current Treatment Options in Oncology. 24(12). 1815–1832. 7 indexed citations

Licata, Luca, Deborah Cosentini, Rita De Sanctis, et al.. (2023). Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group. Frontiers in Oncology. 13. 1081885–1081885. 2 indexed citations

10.

Laganà, Marta, Sara Bosio, Bárbara Zanini, et al.. (2023). Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy. Breast Cancer Research and Treatment. 202(3). 461–471. 3 indexed citations

11.

Delbarba, Andrea, Deborah Cosentini, Marta Laganà, et al.. (2023). Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study. Frontiers in Endocrinology. 14. 1128061–1128061. 1 indexed citations

12.

Zamparini, Manuel, Sara Bosio, Vito Amoroso, et al.. (2022). Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study. Supportive Care in Cancer. 30(8). 6955–6961. 6 indexed citations

13.

Sigala, Sandra, Christina Bothou, David Pentón, et al.. (2022). A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma. Cells. 11(9). 1439–1439. 21 indexed citations

14.

Laganà, Marta, Salvatore Grisanti, Andrea Abate, et al.. (2022). Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen. Endocrine. 77(3). 438–443. 8 indexed citations

15.

Laganà, Marta, Salvatore Grisanti, Roberta Ambrosini, et al.. (2022). Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma. ESMO Open. 7(2). 100422–100422. 13 indexed citations

16.

Rossini, Elisa, Edoardo Giacopuzzi, Fabrizio Gangemi, et al.. (2021). Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α. Biomedicines. 9(6). 681–681. 10 indexed citations

17.

Gurizzan, Cristina, Rebecca Pedersini, Manuel Zamparini, et al.. (2021). Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic. Frontiers in Oncology. 11. 707346–707346. 1 indexed citations

18.

Pedersini, Rebecca, Sara Bosio, Bárbara Zanini, et al.. (2021). Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy. Scientific Reports. 11(1). 12975–12975. 15 indexed citations

19.

Fragni, Martina, Elisa Rossini, Andrea Abate, et al.. (2019). In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆. Molecular and Cellular Endocrinology. 498. 110585–110585. 14 indexed citations

20.

Cosentini, Deborah, Sandra Sigala, Elisa Saba, Elisa Roca, & Alfredo Berruti. (2018). The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma. Translational Cancer Research. 7(4). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact